Literature DB >> 17678893

Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells.

Theresa D'Souza1, Fred E Indig, Patrice J Morin.   

Abstract

Claudin proteins belong to a large family of transmembrane proteins essential to the formation and maintenance of tight junctions (TJs). In ovarian cancer, TJ protein claudin-4 is frequently overexpressed and may have roles in survival and invasion, but the molecular mechanisms underlying its regulation are poorly understood. In this report, we show that claudin-4 can be phosphorylated by protein kinase C (PKC) at Thr189 and Ser194 in ovarian cancer cells and overexpression of a claudin-4 mutant protein mimicking the phosphorylated state results in the disruption of the barrier function. Furthermore, upon phorbol ester-mediated PKC activation of OVCA433 cells, TJ strength is decreased and claudin-4 localization is altered. Analyses using PKC inhibitors and siRNA suggest that PKCepsilon, an isoform typically expressed in ovarian cancer cells, may be important in the TPA-mediated claudin-4 phosphorylation and weakening of the TJs. Furthermore, immunofluorescence studies showed that claudin-4 and PKCepsilon are co-localized at the TJs in these cells. The modulation of claudin-4 activity by PKCepsilon may not only provide a mechanism for disrupting TJ function in ovarian cancer, but may also be important in the regulation of TJ function in normal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678893      PMCID: PMC2034282          DOI: 10.1016/j.yexcr.2007.06.026

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  67 in total

1.  Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells.

Authors:  Y h Chen; Q Lu; E E Schneeberger; D A Goodenough
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

Review 2.  Identification of PKC-isoform-specific biological actions using pharmacological approaches.

Authors:  K J Way; E Chou; G L King
Journal:  Trends Pharmacol Sci       Date:  2000-05       Impact factor: 14.819

3.  Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.

Authors:  Eliana Bignotti; Renata A Tassi; Stefano Calza; Antonella Ravaggi; Chiara Romani; Elisa Rossi; Marcella Falchetti; Franco E Odicino; Sergio Pecorelli; Alessandro D Santin
Journal:  Gynecol Oncol       Date:  2006-05-24       Impact factor: 5.482

Review 4.  Design and use of peptide substrates for protein kinases.

Authors:  B E Kemp; R B Pearson
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 5.  Modification of tight junction function by protein kinase C isoforms.

Authors:  H Clarke; C W Marano; A Peralta Soler; J M Mullin
Journal:  Adv Drug Deliv Rev       Date:  2000-06-30       Impact factor: 15.470

6.  Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium.

Authors:  H Long; C D Crean; W H Lee; O W Cummings; T G Gabig
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

7.  Regulated assembly of tight junctions by protein kinase C.

Authors:  R O Stuart; S K Nigam
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

8.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Authors:  G Martiny-Baron; M G Kazanietz; H Mischak; P M Blumberg; G Kochs; H Hug; D Marmé; C Schächtele
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

9.  Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression.

Authors:  R Engers; S Mrzyk; E Springer; D Fabbro; G Weissgerber; C D Gernharz; H E Gabbert
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

10.  Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells.

Authors:  S Isonishi; K Ohkawa; T Tanaka; S B Howell
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  37 in total

Review 1.  Intestinal barrier function: molecular regulation and disease pathogenesis.

Authors:  Katherine R Groschwitz; Simon P Hogan
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

Review 2.  Biology of claudins.

Authors:  Susanne Angelow; Robert Ahlstrom; Alan S L Yu
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

3.  Role of post translational modifications and novel crosstalk between phosphorylation and O-beta-GlcNAc modifications in human claudin-1, -3 and -4.

Authors:  Azeem Mehmood Butt; Ishaque Badshah Khan; Mureed Hussain; Muhammad Idress; Jun Lu; Yigang Tong
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

4.  Claudin-7 increases chemosensitivity to cisplatin through the upregulation of caspase pathway in human NCI-H522 lung cancer cells.

Authors:  John Hoggard; Junming Fan; Zhe Lu; Qun Lu; Leonard Sutton; Yan-Hua Chen
Journal:  Cancer Sci       Date:  2013-03-29       Impact factor: 6.716

5.  Novel CLDN14 mutations in Pakistani families with autosomal recessive non-syndromic hearing loss.

Authors:  Kwanghyuk Lee; Muhammad Ansar; Paula B Andrade; Bushra Khan; Regie Lyn P Santos-Cortez; Wasim Ahmad; Suzanne M Leal
Journal:  Am J Med Genet A       Date:  2012-01-13       Impact factor: 2.802

6.  Protein kinase C activation has distinct effects on the localization, phosphorylation and detergent solubility of the claudin protein family in tight and leaky epithelial cells.

Authors:  Anita Sjö; Karl-Eric Magnusson; Kajsa Holmgren Peterson
Journal:  J Membr Biol       Date:  2010-08-10       Impact factor: 1.843

7.  Claudin 13, a member of the claudin family regulated in mouse stress induced erythropoiesis.

Authors:  Pamela D Thompson; Hannah Tipney; Andy Brass; Harry Noyes; Steve Kemp; Jan Naessens; May Tassabehji
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

8.  Claudin family of proteins and cancer: an overview.

Authors:  Amar B Singh; Ashok Sharma; Punita Dhawan
Journal:  J Oncol       Date:  2010-07-08       Impact factor: 4.375

9.  Age-related changes of claudin expression in mouse liver, kidney, and pancreas.

Authors:  Theresa D'Souza; Cheryl A Sherman-Baust; Suresh Poosala; James M Mullin; Patrice J Morin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-08-19       Impact factor: 6.053

Review 10.  The claudins.

Authors:  Madhu Lal-Nag; Patrice J Morin
Journal:  Genome Biol       Date:  2009-08-26       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.